Your Location：
Home >
Browse articles >
Da Chaihutang Inhibits Hepatocellular Carcinoma by Regulating p38 MAPK/IL-6/STAT3 Signaling Pathway
Da Chaihutang Inhibits Hepatocellular Carcinoma by Regulating p38 MAPK/IL-6/STAT3 Signaling Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 16, Pages: 19-28(2022)
DOI： 10.13422/j.cnki.syfjx.20221026
Scan QR Code
Full Text(HTML)
Figs( 5 ) Tabs( 7 )
References
Publication Info
Metrics
189
Views
107
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Chemical Constituents，Pharmacological Effect and Clinical Applications of Da Chaihutang： A Review
Action of Immune Microenvironment and Metabolic Reprogramming in Hepatocellular Carcinoma Based on "Deficiency of Healthy Qi and Stasis Toxins"
Mechanism of Xiayuxue Tang in Inhibiting Hepatocellular Carcinoma Cells by Regulating YAP1/SIRT5 Signaling Axis to Mediate Succinate Metabolism and Succinylation
Da Chaihutang for Treatment of Sepsis with Yang Syndrome：A Randomized Controlled Trial
Chinese Medicine Regulates Hepatocellular Carcinoma-related Signaling Pathways： A Review
Related Author
SU Yunmengtong
WANG Danni
LI Huawei
NIU Xiaojing
JIA Guangzong
GUO Huijun
LI Xia
YANG Jiexiong
Related Institution
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine
Medical Research Center for Liver Diseases， The First Affiliated Hospital of Hunan University of Chinese Medicine
Chat
